Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy (OPTI-PP)
Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy in the Hepato-Gastroenterology Department of the Nîmes University Hospital
The main objective of this study is to evaluate the impact of the presence of a pharmacy technician in a care unit (Hepato-Gastroenterology Department) on detected medication errors.
This is a before-after study consisting of three sequential phases:
Month 1: one month of observation of what is happening in the department Month 2: one month wash out period Month 3: active participation of a pharmacy technician in the department
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
The secondary objectives of this study are:
A- To assess the impact of the presence of a pharmacy technician on the ratio of the number of patients with at least one medication error / number of included patients hospitalized in the service.
B- To characterize detected medication errors.
C- To identify and evaluate the potential causes of medication errors.
D- To evaluate whether the presence of a pharmacy technician reduces nursing time spent on medication management.
E- To evaluate the economic impact of the presence of a pharmacy technician.
F- To evaluate the acceptability of the intervention by the nursing staff and pharmacy technicians using questionnaires.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Nîmes Cedex 09, Francja, 30029
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- The patient must be insured or beneficiary of a health insurance plan
- The patient is hospitalized in the Hepato-Gastroenterology Department of the Nîmes University Hospital
Exclusion Criteria:
- The patient is under judicial protection
- The patient, or his/her legal guardian, expresses opposition to participation in the study
- It is impossible to correctly inform the patient
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Zapobieganie
- Przydział: Nielosowe
- Model interwencyjny: Zadanie krzyżowe
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Aktywny komparator: 1st observational period (before experimental intervention)
Patients in this arm are included during a first month of observation before the intervention is implemented. Intervention: One month of department-wide observation |
A pharmacy technician will be present full time in the care unit from Monday to Friday between 8:30 and 17h for 1 month for observational purposes only.
During this phase, the pharmacy technician observes the current practices of preparation and administration of medication by nurses.
He / she will collect medication errors and other observational data.
|
|
Eksperymentalny: 2nd obs. period (during experimental intervention)
Following a one-month wash-out period, patients in this arm are included during a second month of observation during which the intervention is implemented. Intervention: Pharm Tech participates in department |
Following a 1 month wash-out period, a pharmacy technician will again be present full time (in practice, two technicians will relay each other) in the care unit from Monday to Friday between 8:30 and 17h for 1 month.
He/she will actively take part in drug care activities in the department: management of product pathways, verification of injectable preparation, advice, etc. Medication errors and other observational data will be collected.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
The following ratio (relative units): Number of medication errors / number of medications administered and omitted from among all those listed on the prescription for admission
Ramy czasowe: 5 days
|
Primary Outcome Measure as given in protocol: Number of medication errors / number of medications administered and omitted from among all those listed on the prescription for admission (during month 1 versus during month 3).
|
5 days
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Number of patients with at least one medication error / total number of hospitalized patients included in the service
Ramy czasowe: 5 days
|
5 days
|
|
|
For each medication error: the name of the drug
Ramy czasowe: 5 days
|
5 days
|
|
|
For each medication error: the type of error
Ramy czasowe: 5 days
|
Errors are classifies as one of the following types: Omission; Drug; Dosage form; Expired or damaged drug; Dose; Concentration; Frequency of administration; Administration technique; Route of Administration; Rate of administration; Duration of administration; Administration Time; Patient; Drug interaction. |
5 days
|
|
For each medication error: the severity index
Ramy czasowe: 5 days
|
5 days
|
|
|
For each medication error: when (which step) the error occurred during the drug pathway
Ramy czasowe: 5 days
|
The considered steps are: Writing the prescription Medical decision for the prescription Transcription Pharmaceutical analysis Deliverance Preparation / reconstitution Pillbox Administration Procurement Storage Compliance Therapeutic and clinical follow-up |
5 days
|
|
For each medication error: the evolution of the adverse drug event, if occurred
Ramy czasowe: 5 days
|
5 days
|
|
|
For each medication error: the criticality of the error
Ramy czasowe: 5 days
|
Criticality is graded according to the following classes:
3E: treatment or surgery with temporary harm 3F: longer duration of hospitalization with temporary harm 3G: permanent harm 3H: involving a life-threatening harm 3I: death Criticality is determined by the concordance of two, independent expert opinions; or, in case of discordance, the concordance of 2 out 3 expert opinions. |
5 days
|
|
The potential causes of medication errors
Ramy czasowe: 5 days
|
5 days
|
|
|
The average number of interruptions per hour during preparation or administration of drug doses by nurses
Ramy czasowe: 5 days
|
5 days
|
|
|
The number of patients for whom personal treatments were managed by the nursing staff on admission / number of patients who brought their personal treatments to the care unit
Ramy czasowe: 5 days
|
5 days
|
|
|
The number of patients for whom personal treatments were returned by the nursing staff at hospital discharge / number of patients who brought their personal treatments to the care unit
Ramy czasowe: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: the preparation of individual doses
Ramy czasowe: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: ordering health products
Ramy czasowe: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: stock management and exceptional orders
Ramy czasowe: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: the delivery, receipt and storage of health products
Ramy czasowe: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: cabinet inventories
Ramy czasowe: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: the management of expired drugs
Ramy czasowe: 5 days
|
5 days
|
|
|
The number of calls made to the central pharmacy
Ramy czasowe: 5 days
|
5 days
|
|
|
Staff time dedicated to managing exceptional requests
Ramy czasowe: 5 days
|
5 days
|
|
|
The number of drugs consumed
Ramy czasowe: 5 days
|
5 days
|
|
|
The number of medical devices consumed
Ramy czasowe: 5 days
|
5 days
|
|
|
The number of immobilized drugs
Ramy czasowe: 5 days
|
5 days
|
|
|
The number of immobilized medical devices
Ramy czasowe: 5 days
|
5 days
|
|
|
The cost of adverse drug events care
Ramy czasowe: 5 days
|
5 days
|
|
|
Care staff satisfaction questionnaire
Ramy czasowe: 5 days
|
5 days
|
|
|
Pharmacy technician satisfaction questionnaire
Ramy czasowe: 5 days
|
5 days
|
Współpracownicy i badacze
Śledczy
- Dyrektor Studium: Géraldine Leguelinel-Blache, PharmD, PhD, Centre Hospitalier Universitaire de Nîmes
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Inne numery identyfikacyjne badania
- LOCAL/2015/GL-01
- 2015-A01309-40 (Inny identyfikator: RCB number)
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .